RVP-001

N/A

Report date: 2026/02/28 20:00:37
NME

Base Information

Drug NameRVP-001
Drug Alias NameRVP-001Mn-PyC3A
ClassificationDiagnostic agent (In vivo) > Contrast agentSmall molecules > Heterocyclic drugs
Mechanisms of ActionMagnetic resonance imaging enhancers
TargetsUpdating
Therapy Area/IndicationsBrain metastasesNeuroinflammatory DiseasesCentral Nervous System Lymphoma +[16
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsBrain metastasesNeuroinflammatory DiseasesCentral Nervous System Lymphoma +[15
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A